GoodRx Holdings, Inc.
GDRXHealthcareNASDAQHealth Information Services · Last scanned May 29, 2026
Scan Results
Daily timeframePart of the healthcare sector, GoodRx Holdings, Inc. (GDRX) is listed under Health Information Services. Valued at $988.9M, GDRX is a small-cap name in its sector. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.
Market Cap
$988.9M
Beta
1.55
P/E (TTM)
48.67
P/E (Fwd)
8.14
EPS (TTM)
$0.06
EPS (Fwd)
$0.36
ROE
3.2%
ROA
3.5%
Cash
$235.7M
Total Debt
$541.4M
Free CF
$84.6M
52W Change
-23.6%
Annual Financials
Cash vs Debt
GoodRx Holdings, Inc. carries $541.4M in total debt against $235.7M in cash reserves — debt is roughly 2.3x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $84.6M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 3.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.5% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $766.6M (2022) to $796.9M (2025).
GoodRx Holdings, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing GDRX.